These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 18788394)

  • 1. [Metabolic and immunological disorder in CKD].
    Yasuda Y; Yuzawa Y; Matsuo S
    Nihon Rinsho; 2008 Sep; 66(9):1678-86. PubMed ID: 18788394
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evidence-based practice guideline for the treatment of CKD].
    CKD Guideline Editorial Committee
    Nihon Jinzo Gakkai Shi; 2009; 51(8):905-1066. PubMed ID: 19999585
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolic and clinical consequences of metabolic acidosis.
    Mitch WE
    J Nephrol; 2006; 19 Suppl 9():S70-5. PubMed ID: 16736444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic kidney disease (CKD) and bone. Chronic kidney disease--mineral and bone disorder in predialysis patients].
    Inaguma D; Tatematsu M
    Clin Calcium; 2009 Apr; 19(4):493-9. PubMed ID: 19329827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid disorders in chronic kidney disease: reverse epidemiology and therapeutic approach.
    Chmielewski M; Carrero JJ; Nordfors L; Lindholm B; Stenvinkel P
    J Nephrol; 2008; 21(5):635-44. PubMed ID: 18949717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Parathyroid and bone. Mineral and bone disorder and parathyroid function in chronic kidney disease].
    Yano S
    Clin Calcium; 2007 Dec; 17(12):1870-8. PubMed ID: 18057663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CKD-MBD (chronic kidney disease-mineral and bone disorder). CKD-MBD: chronic kidney disease-mineral and bone disorder].
    Mizobuchi M; Aoshima Y; Akizawa T
    Clin Calcium; 2010 Jul; 20(7):995-1003. PubMed ID: 20585177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Atheroma and vascular calcification in hemodialysis patients].
    Joki N; Tanaka Y
    Clin Calcium; 2010 Jul; 20(7):1061-6. PubMed ID: 20585185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Bone metabolism in CKD-MBD].
    Kazama JJ
    Clin Calcium; 2010 Jul; 20(7):1038-44. PubMed ID: 20585182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease.
    Wahba IM; Mak RH
    Clin J Am Soc Nephrol; 2007 May; 2(3):550-62. PubMed ID: 17699463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of lipid metabolism in chronic nephropathies: mechanisms, diagnosis and treatment.
    Lacquaniti A; Bolignano D; Donato V; Bono C; Fazio MR; Buemi M
    Kidney Blood Press Res; 2010; 33(2):100-10. PubMed ID: 20357496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of chronic kidney disease in hypertensive patients with other metabolic conditions.
    Weycker D; Nichols GA; O'Keeffe-Rosetti M; Edelsberg J; Vincze G; Khan ZM; Oster G
    J Hum Hypertens; 2008 Feb; 22(2):132-4. PubMed ID: 17728802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sodium bicarbonate to slow the progression of chronic kidney disease].
    Rossier A; Bullani R; Burnier M; Teta D
    Rev Med Suisse; 2011 Mar; 7(284):478-82. PubMed ID: 21462516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Secondary osteoporosis UPDATE. Bone disease with decreased kidney function].
    Okuno S; Ishimura E
    Clin Calcium; 2010 May; 20(5):655-62. PubMed ID: 20445276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Introduction. CKD-MBD (Chronic kidney disease-Metabolic bone disease)].
    Cozzolino M; Mazzaferro S
    G Ital Nefrol; 2009; 26 Suppl 49():S1. PubMed ID: 19941271
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic kidney disease (CKD) and bone. Management of chronic kidney disease-mineral and bone disorder in peritoneal dialysis patients].
    Yaginuma T; Yamamoto H
    Clin Calcium; 2009 Apr; 19(4):508-13. PubMed ID: 19329829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology of cardiovascular disease in CKD-MBD].
    Di Micco L; Mozzillo GR; Cianciaruso B
    G Ital Nefrol; 2009; 26 Suppl 49():S3-10. PubMed ID: 19941272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dyslipidemia as a therapeutic target for prevention of cardiovascular events and end-stage renal disease].
    Watanabe T
    Nihon Rinsho; 2008 Sep; 66(9):1761-9. PubMed ID: 18788407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid metabolism in chronic kidney disease: the role of statins in cardiovascular risk.
    Wanner C; Drechsler C; Krane V
    J Ren Nutr; 2007 Jan; 17(1):75-8. PubMed ID: 17198938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease/bone and mineral metabolism: the imperfect storm.
    Williams ME
    Semin Nephrol; 2009 Mar; 29(2):97-104. PubMed ID: 19371800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.